• 09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

  • Nov 27 2023
  • Durée: 34 min
  • Podcast

09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

    In Part I: PTCy and Improved Outcomes, experts highlight the history of GVHD prevention and the impacts of post-transplant cyclophosphamide (PTCy) in particular in improving outcomes and closing gaps in access to care.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Voir plus Voir moins
activate_WEBCRO358_DT_T2
activate_samplebutton_t1
Troubles et maladies Hygiene & Healthy Living
Voir plus Voir moins

Ce que les auditeurs disent de 09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.